The present invention relates to the use of a progestin selected from progesterone, synthetic progestin and a combination thereof in the treatment or prevention of neurodegeneration or neuronal damage following a traumatic or ischemic injury to the central nervous system (CNS), said use comprising a tapered administration dosing regimen of the progestin prior to termination of administration..